India’s Hetero Labs Ltd said it received local regulatory approval to launch its version of anti-viral drug favipiravir for the treatment of COVID-19.

The drug, priced at 59 rupees (79 US cents) per tablet, will be available at drug stores from Wednesday, privately held Hetero said. 

Source:aljazeera.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Scientists Probe Cannabis And Nicotine Resistance To COVID-19

Smokers who initially were thought to be one of the most vulnerable…

Coronavirus: Trump Gives WHO Ultimatum Over COVID-19 Handling

US President Donald Trump has sent a letter to the head of…

Coronavirus: British Airways Suspends All Flights To Mainland China

British Airways has suspended all direct flights to and from mainland  China…

George Floyd: Protesters Set Minneapolis Police Station Ablaze

A police station in Minneapolis has been set alight during a third…